January 16, 2025
Dollar weakens after CPI shows cooling inflation; yen firms on BOJ talk
The dollar weakened against major peers after cooler-than-expected data eased fears that inflation was accelerating and increased the chances the Federal Reserve could cut interest rates twice this year. The Bureau of Labor Statistics showed consumer prices rose 2.9% in the 12 months through December, in line with economists’ expectations. The Dollar-Yen pair dropped 0.9% […]
Read More
January 16, 2025
Cooler core inflation revives bets on Fed rate cuts
Fed policymakers may be able to reduce interest rates a couple of times this year, after a government report helped allay fears that inflation was accelerating in the final full month of Joe Biden’s presidency. The core consumer price index, which excludes food and energy prices and is seen as a gauge of underlying inflation […]
Read More
January 15, 2025
Boeing jet deliveries in 2024 drop to lowest since pandemic
Deliveries of new Boeing jets bounced back in December after a crippling labor strike that slowed production last fall, but the company’s annual deliveries dropped in 2024 to the lowest level since the COVID-19 pandemic.
Read More
January 15, 2025
The dollar fell against the euro
The dollar fell against the euro but was still hovering near its highest level in more than two years as the first of two inflation readings this week provided little assurance the U.S. Federal Reserve will soon cut interest rates. The Euro gained 0.5% against the Dollar in the last session. The Ultimate Oscillator’s is […]
Read More
January 15, 2025
Wall Street rises in choppy trade
U.S. stocks rose modestly in choppy trade as investors gauged inflation data and braced for quarterly earnings reports to justify stock valuations and the strength of the U.S. economy. Stocks received an initial lift after a Labor Department report showed the producer price index rose less than expected in December.
Read More
January 14, 2025
J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal
Johnson & Johnson said it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the market for brain disease treatments. The deal would help accelerate growth in J&J’s drugs business after the company spun off its consumer health unit in 2023.
Read More
